Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 8:17:1542607.
doi: 10.3389/fnagi.2025.1542607. eCollection 2025.

Alzheimer's disease and insomnia: a bibliometric study and visualization analysis

Affiliations
Review

Alzheimer's disease and insomnia: a bibliometric study and visualization analysis

Zi-Yue Tian et al. Front Aging Neurosci. .

Abstract

Background: Alzheimer's disease (AD) is the fastest-growing neurodegenerative disorder globally, with patient numbers expected to rise to 130 million by 2050. Insomnia, a prevalent comorbidity, exhibits a bidirectional relationship with AD: insomnia accelerates AD pathology, while AD worsens sleep disorders. This relationship has emerged as a key area of research. Current mechanisms involve oxidative stress, inflammatory responses, and glymphatic system dysfunction, yet a comprehensive review of these processes remains absent.

Objective: To conduct a visual analysis of the relationship between Alzheimer's disease and insomnia using CiteSpace.

Methods: Literature on "insomnia" and "Alzheimer's disease" published between January 1, 2000, and October 31, 2024, was retrieved from the Web of Science Core Collection. CiteSpace and VOSviewer software were used to analyze institutions, authors, and keywords.

Results: A total of 1,907 articles were analyzed, revealing a consistent upward trend in publication volume. The United States and the Mayo Clinic were identified as leading contributors, producing 704 and 57 publications, respectively. Boeve Bradley F the most prolific author contributed 30 publications. Collaboration was actively observed among countries, institutions, and authors. High-frequency keywords identified were "Parkinson's disease," "cognitive impairment," and "sleep behavior disorder." Emerging research areas are likely to focus on "sleep quality" and the "glymphatic system."

Conclusion: This study is the first to apply bibliometric analysis to identify three key trends in AD and insomnia research: the dominance of the United States and Mayo Clinic, strong international collaboration, and a focus on critical areas such as cognitive impairment, the glymphatic system, and sleep interventions. Insomnia may accelerate AD progression via multiple pathways, indicating that enhancing sleep quality could provide new strategies for early intervention. Future research should prioritize advancing the clinical translation of sleep interventions and investigating the mechanisms of the glymphatic system.

Keywords: Alzheimer's disease; CiteSpace; VOSviewer; bibliometrics; insomnia; visual analysis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer WZ declared a shared affiliation with the authors MJ, X-KY to the handling editor at the time of review.

Figures

Figure 1
Figure 1
Flowchart of data screening and bibliometric analysis.
Figure 2
Figure 2
Distribution of documents by type.
Figure 3
Figure 3
Annual publication trends. Shows the global publication volume from 2000 to 2024, with the fitted formula y = 6.3893x.
Figure 4
Figure 4
Collaboration network among countries and regions. The size of the nodes represents publication volume, while the thickness of the connecting lines indicates the strength of collaboration (TLS ≥ 10). Only 48 countries with publication volumes ≥5 are displayed. Six collaboration clusters, each represented by a different color, were formed, with a total connection strength of 1,753.
Figure 5
Figure 5
Institutional collaboration network. The size of the nodes represents publication volume, while the thickness of the connecting lines indicates collaboration strength (TLS ≥ 10). There are 2,862 institutions in total, with 216 institutions displaying a publication volume of 5 or more. Fourteen collaboration clusters, each represented by a different color, were formed, with a total connection strength of 1,913.
Figure 6
Figure 6
Author collaboration network. There are 9,560 authors in total. The size of the nodes represents publication volume, while the thickness of the connecting lines indicates collaboration strength (TLS ≥ 10). Only 96 authors with a publication volume of 5 or more are displayed. Eight collaboration clusters, each represented by a different color, were formed, with a total connection strength of 1,043.
Figure 7
Figure 7
Keyword co-occurrence map.
Figure 8
Figure 8
Keyword clustering map. The map illustrates ten distinct research clusters, each represented by a unique color. Cluster #0 dementia, Cluster #1 sleep deprivation, Cluster #2 dementia with lewy bodies, Cluster #3 locus coeruleus, Cluster #4 circadian rhythms, Cluster #5 fatal familial insomnia, Cluster #6 toxicity, Cluster #7 rem sleep, Cluster #8 Alzheimer's disease, Cluster #9 mendelian randomization.
Figure 9
Figure 9
Citation burst analysis of the top 25 keywords. Since 2021, three keywords—“sleep quality,” “glymphatic system,” and “sleep disorder”—have seen a significant increase in citations.
Figure 10
Figure 10
Timeline map of keywords related to Alzheimer's disease and insomnia (2000–2024).

References

    1. Abad V., Guilleminault C. (2018). Insomnia in elderly patients: recommendations for pharmacological management. Drugs Aging 35, 791–817. 10.1007/s40266-018-0569-8 - DOI - PubMed
    1. Alvaro P. K., Roberts R. M., Harris J. K. (2013). A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep 36, 1059–1068. 10.5665/sleep.2810 - DOI - PMC - PubMed
    1. Anderson E. L., Richmond R. C., Jones S. E., Hemani G., Wade K. H., Dashti H. S., et al. . (2021). Is disrupted sleep a risk factor for Alzheimer's disease? Evidence from a two-sample mendelian randomization analysis. Int. J. Epidemiol. 50, 817–828. 10.1093/ije/dyaa183 - DOI - PMC - PubMed
    1. Arvanitakis Z., Shah R. C., Bennett D. A. (2019). Diagnosis and management of dementia: review. JAMA 322, 1589–1599. 10.1001/jama.2019.4782 - DOI - PMC - PubMed
    1. Atkin T., Comai S., Gobbi G. (2018). Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery. Pharmacol. Rev. 70, 197–245. 10.1124/pr.117.014381 - DOI - PubMed

LinkOut - more resources